Jörg Hartkamp
-
- Renal and related cancers 4
- Cell death mechanisms and regulation 3
- Melanoma and MAPK Pathways 2
- Protein Kinase Regulation and GTPase Signaling 2
- Histone Deacetylase Inhibitors Research 2
- Glycosylation and Glycoproteins Research 1
-
- PARP inhibition in cancer therapy 3
-
- Renal cell carcinoma treatment 2
- Co-authors
- Stefan G. E. RobertsUlf R. RappJakob TroppmairBrian CarpenterJulian R. SampsonAnja JaeschkeRichard F. LambTakahiro Nobukuni
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Jörg Hartkamp
16 papers receiving 531 citations
Peers
Comparison fields: 5 of 66
- Molecular Biology 426
- Oncology 130
- Cancer Research 63
- Cell Biology 56
- Physiology 85
Countries citing papers authored by Jörg Hartkamp
This map shows the geographic impact of Jörg Hartkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jörg Hartkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jörg Hartkamp more than expected).
Fields of papers citing papers by Jörg Hartkamp
This network shows the impact of papers produced by Jörg Hartkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jörg Hartkamp. The network helps show where Jörg Hartkamp may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jörg Hartkamp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 4 | |
| 2 | 2021 | 1 | |
| 3 | 2019 | 17 | |
| 4 | 2018 | 13 | |
| 5 | 2017 | 22 | |
| 6 | 2016 | 1 | |
| 7 | 2014 | 22 | |
| 8 | 2013 | 49 | |
| 9 | 2012 | 44 | |
| 10 | 2010 | 8 | |
| 11 | 2010 | 63 | |
| 12 | 2008 | 24 | |
| 13 | 2002 | 5 | |
| 14 | 2002 | 167 | |
| 15 | The JNK/SAPK activator mixed lineage kinase 3 (MLK3) transforms NIH 3T3 cells in a MEK-dependent fashion. | 1999 | 57 |
| 16 | 1998 | 44 |
About Jörg Hartkamp
Jörg Hartkamp is a scholar working on Oncology, Modeling and Simulation and Molecular Biology, having authored 16 papers that have together received 541 indexed citations. Recurring topics across this work include Renal and related cancers (4 papers), Cell death mechanisms and regulation (3 papers), PARP inhibition in cancer therapy (3 papers), Renal cell carcinoma treatment (2 papers), Melanoma and MAPK Pathways (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Molecular Biology (426 citations), Oncology (130 citations) and Cancer Research (63 citations). Jörg Hartkamp has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Stefan G. E. Roberts, Ulf R. Rapp, Jakob Troppmair, Brian Carpenter, Julian R. Sampson, Anja Jaeschke, Richard F. Lamb, Takahiro Nobukuni, Wendy Wassyng Roworth and George Thomas. Their work appears in journals such as The Journal of Cell Biology, Molecular Cell and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.